Polypharm Flashcards
Vital sign changes in the elderly
- BP (systolic HTN, ortho hypo)
- HR slows
- Hypothermia
Skin changes in the elderly
- Vascularity of dermis decreases
- Thin, fragile, loose skin
- Actinic purpura (blood that has leaked through poorly supported capillaries)
Head and neck changes in the elderly
- Dry eyes
- Visual acuity diminishes
- Lens changes increasing risk for cataracts, glaucoma, macular degeneration
- Decreased salivation, taste
- Periodontal disease
Lungs and thorax changes in the elderly
- Stiffer chest wall
- Resp muscles weaken
- Lungs lose elastic recoil
- Cough less effective
CV system changes in the elderly
- Systolic bruits in carotids
- Extra heart sounds
- Cardiac murmurs
MC complaint of the elderly?
Memory changes
Scoring of MMSE
0-30
Scores over 25 are normal
Typical MMSE score of Alzheimer’s patients?
19-24
Pharmacokinetic absorption changes in the elderly
- Decreased acid secretion
- Delayed emptying
- Slowed transit time
- Reduce blood flow
Pharmacokinetic distribution changes in the elderly
- Body fat increases, muscle mass decreases
- Meds that distribute into fat stick around longer (e.g. Diazepam, chlordiazepoxide)
- Meds that distribute into muscle or body water don’t distribute as much (e.g. Lithium)
Pharmacokinetic protein binding changes in the elderly
- Serum albumin usually doesn’t change in healthy older adults, but REDUCED in frail or malnourished elderly
- A lot more drug distributing freely and not protein bound (e.g. phenytoin, warfarin, diazepam)
Pharmacokinetic metabolism changes in the elderly
Liver mass and blood flow can be reduced (meds with a high first pass rate will show higher bioavailability so lower doses should be given)
Pharmacokinetic excretion changes in the elderly
- Reduction in renal mass, BF, GFR
- Serum Cr is NOT accurate in older adults due to decreased muscle mass (so use CrCl instead)
Describe ADEs in the elderly
95% are predictable
28% preventable
What causes ADRs in the elderly?
- Polypharm
- Multiple comorbidities
- Poor med adherence
- Age related PK and PD changes
Risk factors for polypharmacy
- Females
- Institutionalized
- Comorbidities
- Over 65 yo
- Cognitive impairments